HRP20050703A2 - Pyridine derivatives useful for inhibiting sodium/calcium exchange system - Google Patents

Pyridine derivatives useful for inhibiting sodium/calcium exchange system Download PDF

Info

Publication number
HRP20050703A2
HRP20050703A2 HR20050703A HRP20050703A HRP20050703A2 HR P20050703 A2 HRP20050703 A2 HR P20050703A2 HR 20050703 A HR20050703 A HR 20050703A HR P20050703 A HRP20050703 A HR P20050703A HR P20050703 A2 HRP20050703 A2 HR P20050703A2
Authority
HR
Croatia
Prior art keywords
yloxy
pyridin
chroman
nmr
mhz
Prior art date
Application number
HR20050703A
Other languages
English (en)
Croatian (hr)
Inventor
Otsomaa Leena
Koskelainen Tuula
Karjalainen Arto
Rasku Sirpa
Pollesello Piero
Levijoki Jouko
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8565286&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20050703(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of HRP20050703A2 publication Critical patent/HRP20050703A2/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D411/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR20050703A 2003-01-09 2005-08-08 Pyridine derivatives useful for inhibiting sodium/calcium exchange system HRP20050703A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20030030A FI20030030A0 (fi) 2003-01-09 2003-01-09 Uusia yhdisteitä
PCT/FI2004/000011 WO2004063191A1 (en) 2003-01-09 2004-01-09 Pyridine derivatives useful for inhibiting sodium/calcium exchange system

Publications (1)

Publication Number Publication Date
HRP20050703A2 true HRP20050703A2 (en) 2005-10-31

Family

ID=8565286

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20050703A HRP20050703A2 (en) 2003-01-09 2005-08-08 Pyridine derivatives useful for inhibiting sodium/calcium exchange system

Country Status (22)

Country Link
US (1) US7482340B2 (uk)
EP (1) EP1583759A1 (uk)
JP (1) JP2006516271A (uk)
KR (1) KR20050095601A (uk)
CN (1) CN100457752C (uk)
AR (1) AR042733A1 (uk)
AU (1) AU2004203943B2 (uk)
BR (1) BRPI0406669A (uk)
CA (1) CA2512184A1 (uk)
EA (1) EA008539B1 (uk)
FI (1) FI20030030A0 (uk)
HR (1) HRP20050703A2 (uk)
IL (1) IL169435A0 (uk)
IS (1) IS7969A (uk)
MX (1) MXPA05007435A (uk)
NO (1) NO20053730L (uk)
NZ (1) NZ541087A (uk)
PL (1) PL378326A1 (uk)
RS (1) RS20050528A (uk)
UA (1) UA81941C2 (uk)
WO (1) WO2004063191A1 (uk)
ZA (1) ZA200505461B (uk)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20011507A0 (fi) * 2001-07-10 2001-07-10 Orion Corp Uusia yhdisteitä
KR101233223B1 (ko) * 2004-12-21 2013-02-14 제이엔씨 석유 화학 주식회사 크로만환을 가지는 액정 화합물, 액정 조성물 및 이 액정조성물을 함유하는 액정 표시소자
UA109896C2 (xx) 2007-02-22 2015-10-26 Похідні імінопіридину та їх застосування як мікробіоцидів
JP5913357B2 (ja) * 2010-12-06 2016-04-27 アウトイフオンイ トヘラペウトイクス リミテッド Kv3阻害剤として有用なヒダントイン誘導体
EP2524908A1 (en) 2011-05-20 2012-11-21 LEK Pharmaceuticals d.d. Process for the preparation of alfa-substituted ketones and their application in synthesis of pharmaceutically active compounds
PT2567958E (pt) * 2011-09-12 2015-01-14 Sanofi Sa 2-(croman-6-iloxi)-tiazoles substituídos e sua utilização como produtos farmacêuticos
JP5941637B2 (ja) * 2011-09-12 2016-06-29 サノフイ 置換2−(クロマン−6−イルオキシ)−チアゾール及び医薬としてのその使用
US8912224B2 (en) 2011-09-12 2014-12-16 Sanofi Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
KR101817925B1 (ko) 2011-09-12 2018-01-12 사노피 치환된 2-(크로만-6-일옥시)-티아졸 및 약제로서의 이의 용도
WO2013144191A1 (de) * 2012-03-29 2013-10-03 Bayer Intellectual Property Gmbh Substituierte 2 -amino - 3 - cyanopyridine als inhibitoren des natrium calcium austausches und ihre verwendung bei kardiovaskulären erkrankungen
TWI633095B (zh) 2013-03-08 2018-08-21 賽諾菲公司 經取代-6-基氧基-環烷類及其作為醫藥品之用途
GB201416186D0 (en) 2014-09-12 2014-10-29 Redx Pharma Ltd Compounds
KR102594441B1 (ko) 2015-03-06 2023-10-25 파마케아, 인크. 플루오르화된 리실 옥시다아제-유사 2 억제제 및 이의 용도
EP3265445B1 (en) 2015-03-06 2021-05-05 Pharmakea, Inc. Lysyl oxidase-like 2 inhibitors and uses thereof
KR102573450B1 (ko) * 2015-08-19 2023-08-31 닛산 가가쿠 가부시키가이샤 액정 배향제 등에 사용되는 신규의 이미드계 중합체
CN109983006B (zh) 2016-09-07 2022-02-25 法玛克亚公司 赖氨酰氧化酶样2抑制剂的结晶形式及其制备方法
CN117180280A (zh) 2016-09-07 2023-12-08 法玛克亚公司 赖氨酰氧化酶样2抑制剂的用途
WO2019175464A1 (en) 2018-03-14 2019-09-19 Orion Corporation Compounds useful as inhibitors of sodium-calcium exchanger (ncx)
CA3187514A1 (en) 2020-07-28 2022-02-03 Andrew BELFIELD Fused bicyclic raf inhibitors and methods for use thereof
CN115850258B (zh) * 2022-12-27 2024-09-24 东北林业大学 一种马赛替尼的合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2820817A (en) 1954-02-04 1958-01-21 Mcneilab Inc Oxygenated indan compounds and method of making the same
US3862232A (en) 1963-07-03 1975-01-21 Upjohn Co 1-(p-hydroxyphenyl)-2-phenyl-6-(2-diethylaminoethoxy)-3,4-dihydronaphthalene and the salts thereof
BE650081A (uk) 1963-07-03
GB1154119A (en) 1968-05-20 1969-06-04 Merck Ag E 3-Alkyl-Flavanones
JPH04113839A (ja) * 1990-09-05 1992-04-15 Mitsubishi Petrochem Co Ltd ポリカーボネート樹脂積層物
FR2733685B1 (fr) 1995-05-05 1997-05-30 Adir Utilisation des derives du benzopyrane pour l'obtention de compositions pharmaceutiques destinees au traitement des pathologies liees a l'echangeur c1-/hc03-, na+ independant
JPH0967336A (ja) 1995-09-04 1997-03-11 Kanebo Ltd 新規なイソチオウレア誘導体
US6156801A (en) 1997-03-27 2000-12-05 Taisho Pharmaceutical Co., Ltd. 2-phenoxyaniline derivatives
JPH1149752A (ja) * 1997-08-05 1999-02-23 Taisho Pharmaceut Co Ltd フェノキシピリジン誘導体
DE19742508A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
KR20010031212A (ko) 1997-10-20 2001-04-16 우에하라 아끼라 2-페녹시아닐린 유도체
JPH11302235A (ja) 1998-04-15 1999-11-02 Taisho Pharmaceut Co Ltd フェノキシアルキルアミン誘導体
AU4360200A (en) 1999-04-23 2000-11-10 Bristol-Myers Squibb Company Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
SK3292002A3 (en) 1999-09-17 2003-04-01 Nissan Chemical Ind Ltd Benzopyran derivative
FI20011507A0 (fi) * 2001-07-10 2001-07-10 Orion Corp Uusia yhdisteitä

Also Published As

Publication number Publication date
ZA200505461B (en) 2006-03-29
US20060241147A1 (en) 2006-10-26
BRPI0406669A (pt) 2005-12-20
AU2004203943A1 (en) 2004-07-29
WO2004063191A1 (en) 2004-07-29
IS7969A (is) 2005-08-02
CN100457752C (zh) 2009-02-04
US7482340B2 (en) 2009-01-27
NO20053730D0 (no) 2005-08-03
JP2006516271A (ja) 2006-06-29
EP1583759A1 (en) 2005-10-12
IL169435A0 (en) 2007-07-04
EA008539B1 (ru) 2007-06-29
CA2512184A1 (en) 2004-07-29
AU2004203943B2 (en) 2009-09-17
NO20053730L (no) 2005-10-07
AR042733A1 (es) 2005-06-29
CN1745078A (zh) 2006-03-08
UA81941C2 (uk) 2008-02-25
RS20050528A (en) 2007-06-04
PL378326A1 (pl) 2006-03-20
FI20030030A0 (fi) 2003-01-09
NZ541087A (en) 2008-04-30
MXPA05007435A (es) 2005-09-12
EA200501104A1 (ru) 2005-12-29
KR20050095601A (ko) 2005-09-29

Similar Documents

Publication Publication Date Title
HRP20050703A2 (en) Pyridine derivatives useful for inhibiting sodium/calcium exchange system
KR101410318B1 (ko) 바닐로이드 수용체 길항제로서의 신규 화합물, 그의 이성질체, 또는 약제학적으로 허용가능한 그의 염, 및 이를함유하는 약제학적 조성물
KR0142417B1 (ko) 3급알킬작용성화된피레라진유도체
AU2014355887B2 (en) Urea derivative or pharmacologically acceptable salt thereof
CA2369103A1 (en) Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same
WO2006117609A2 (en) Phenoxypropylpiperidines and -pyrrolidines and their use as histamine h3 -receptor ligands
CN111183130B (zh) 苯并杂环衍生物及包含其的医药组合物
ES2269746T3 (es) Compuestos, que son potentes inhibidores del mecanismo de intercambio na+/ca2+ y que son utiles en el tratamiento de arritmias.
CN101522674A (zh) 作为香草酸受体拮抗剂的新化合物或其药物学可接受的盐、及包含这些化合物的药物组合物
AU2002321339A1 (en) New compounds, which are potent inhibitors of NA+/CA2+ exchange mechanism and are useful in the treatment of arrhythmias
AU2014312756B2 (en) Novel aromatic compound and use thereof
CN116056706A (zh) 可用作二酰基甘油酰基转移酶2抑制剂的新的联芳基衍生物及其用途
JP2009179562A (ja) グリシントランスポーター阻害剤
KR20060067738A (ko) 바닐로이드 수용체의 길항제로서 강력한 진통효과를나타내는 신규한 n-아릴아마이드 유도체 및 이를함유하는 약제학적 조성물
Koskelainen et al. Compounds, which are potent inhibitors of Na+/Ca 2+ exchange mechanism and are useful in the treatment of arrhythmias
PT2054411E (pt) Novos compostos, isómeros dos mesmos, ou sais farmaceuticamente aceitáveis dos mesmos como antagonistas do recetor vanilóide e composições farmacêuticas contendo os mesmos

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20091221

Year of fee payment: 7

OBST Application withdrawn